Clinical Trial Update: Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial comparing darunavir/ritonavir + lamivudine versus darunavir/ritonavir + emtricitabine/tenofovir in treatment-naïve HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• darunavir/ritonavir + emtricitabine/tenofovir
• darunavir/ritonavir + lamivudine

Snippet

Sponsor: Fundación Huésped | Conditions: HIV-1 Infection | Phase 4 | Status: COMPLETED